These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30462843)
1. Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia. Vassilaki M; Aakre JA; Kremers WK; Mielke MM; Geda YE; Machulda MM; Knopman DS; Coloma PM; Schauble B; Vemuri P; Lowe VJ; Jack CR; Petersen RC; Roberts RO J Am Geriatr Soc; 2018 Dec; 66(12):2274-2281. PubMed ID: 30462843 [TBL] [Abstract][Full Text] [Related]
2. Brain amyloid, cortical thickness, and changes in activities of daily living. Vassilaki M; Aakre JA; Kremers WK; Lesnick TG; Mielke MM; Geda YE; Machulda MM; Knopman DS; Butler L; Traber M; Vemuri P; Lowe VJ; Jack CR; Roberts RO; Petersen RC Ann Clin Transl Neurol; 2020 Apr; 7(4):474-485. PubMed ID: 32314554 [TBL] [Abstract][Full Text] [Related]
3. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479 [TBL] [Abstract][Full Text] [Related]
4. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community. Petersen RC; Wiste HJ; Weigand SD; Rocca WA; Roberts RO; Mielke MM; Lowe VJ; Knopman DS; Pankratz VS; Machulda MM; Geda YE; Jack CR JAMA Neurol; 2016 Jan; 73(1):85-92. PubMed ID: 26595683 [TBL] [Abstract][Full Text] [Related]
5. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. Jack CR; Wiste HJ; Therneau TM; Weigand SD; Knopman DS; Mielke MM; Lowe VJ; Vemuri P; Machulda MM; Schwarz CG; Gunter JL; Senjem ML; Graff-Radford J; Jones DT; Roberts RO; Rocca WA; Petersen RC JAMA; 2019 Jun; 321(23):2316-2325. PubMed ID: 31211344 [TBL] [Abstract][Full Text] [Related]
6. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]
8. The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons. Vassilaki M; Aakre JA; Kremers WK; Mielke MM; Geda YE; Alhurani RE; Dutt T; Machulda MM; Knopman DS; Vemuri P; Coloma PM; Schauble B; Lowe VJ; Jack CR; Petersen RC; Roberts RO J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):877-883. PubMed ID: 30124772 [TBL] [Abstract][Full Text] [Related]
9. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies. Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100 [TBL] [Abstract][Full Text] [Related]
10. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals. Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843 [TBL] [Abstract][Full Text] [Related]
11. Continuous Associations between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer's Disease. Boots EA; Frank RD; Fan WZ; Christianson TJ; Kremers WK; Stricker JL; Machulda MM; Fields JA; Hassenstab J; Graff-Radford J; Vemuri P; Jack CR; Knopman DS; Petersen RC; Stricker NH J Prev Alzheimers Dis; 2024; 11(5):1467-1479. PubMed ID: 39350394 [TBL] [Abstract][Full Text] [Related]
12. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia. Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563 [TBL] [Abstract][Full Text] [Related]
13. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults. Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697 [TBL] [Abstract][Full Text] [Related]
14. Association of moderate alcohol intake with in vivo amyloid-beta deposition in human brain: A cross-sectional study. Kim JW; Byun MS; Yi D; Lee JH; Ko K; Jeon SY; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY; PLoS Med; 2020 Feb; 17(2):e1003022. PubMed ID: 32097439 [TBL] [Abstract][Full Text] [Related]
15. Association of Excessive Daytime Sleepiness With Longitudinal β-Amyloid Accumulation in Elderly Persons Without Dementia. Carvalho DZ; St Louis EK; Knopman DS; Boeve BF; Lowe VJ; Roberts RO; Mielke MM; Przybelski SA; Machulda MM; Petersen RC; Jack CR; Vemuri P JAMA Neurol; 2018 Jun; 75(6):672-680. PubMed ID: 29532057 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting. Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment. Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054 [TBL] [Abstract][Full Text] [Related]
18. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study. Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S; J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728 [TBL] [Abstract][Full Text] [Related]
19. Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals. Berti V; Murray J; Davies M; Spector N; Tsui WH; Li Y; Williams S; Pirraglia E; Vallabhajosula S; McHugh P; Pupi A; de Leon MJ; Mosconi L J Nutr Health Aging; 2015 Apr; 19(4):413-23. PubMed ID: 25809805 [TBL] [Abstract][Full Text] [Related]
20. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]